Type II Diabetes Mellitus Clinical Trials

98 clinical trials for Type II Diabetes Mellitus across international registries, including 9 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• The GRoceries Aimed at Increasing Nutrition Study — RECRUITING · NA
• A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus — RECRUITING · PHASE2
• cfMSC Therapy for Diabetes — RECRUITING · PHASE1
• Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus — RECRUITING · PHASE2
• Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency — RECRUITING · PHASE1
• Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study — RECRUITING · PHASE4
• Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors — RECRUITING · NA
• Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D] — RECRUITING · NA
• Feasibility Trial in Urban Pakistan for Community Engagement in Preventing Type II Diabetes and Risk Factors — RECRUITING · NA
• A multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and safety of SYR110322 (SYR-322) Compared with Placebo in Subjects with Type 2 Diabetes — COMPLETED · PHASE3
• A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate Safety and Efficacy of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin — TERMINATED · PHASE3
• A study to look at the effectiveness and safety of of Alogliptin Plus Metformin, Alogliptin Alone, or Metformin Alone in Subjects with Diabetes — COMPLETED · PHASE3
• Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration for the Treatment of Hyperglycemia in Metformin Monotherapy Treated Type 2 Diabetic Patients: a Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study — TERMINATED · PHASE3
• A Long-Term, Open-Label Extension Study to Investigate the Long-Term Safety of SYR110322 (SYR-322) in Subjects with Type 2 Diabetes — COMPLETED · PHASE3
• A Phase IIa, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Assess the Safety, Tolerability and Activity of Oral SRT2104 Capsules Administered for 28 days to Subjects with Type 2 Diabetes Mellitus. — COMPLETED · PHASE2
• COMPARISON OF TWO THERAPEUTIC STRATEGIES FOR TREATING TYPE 2 DIABETIC PATIENTS POORLY CONTROLLED WITH BASAL INSULIN ASSOCIATED WITH ORAL ANTIDIABETIC DRUGS: 6-MONTH PROOF OF CONCEPT STUDY — COMPLETED · PHASE4
• A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes Mellitus and End-Stage Renal Disease Who Are on Dialysis and Who Have Inadequate Glycemic Control — COMPLETED · PHASE3
• This study aims to clarify if a tetracycline antibiotic (minocycline) can help the heart and blood vessels in patients with diabetes and who have high levels of a blood protein called Matrix Metalloproteinase-9 (MMP-9). — COMPLETED · PHASE2
• A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate the Effect of Tesaglitazar 1 mg once daily on the Pharmacokinetics of Metformin Following Addition of Tesaglitazar to Metformin Treatment twice daily in Patients with Type 2 Diabetes — TERMINATED · PHASE2
• An Open-label, Multi-Centre and Long-Term Extension Study to Evaluate the Safety and Tolerability of oral Tesaglitazar 1 mg in patients with Type 2 Diabetes. — COMPLETED · PHASE3
• Efficacy and safety of insulin glargine/lixisenatide fixed combination versus insulin glargine alone on top of metformin in type 2 diabetic patients — COMPLETED · PHASE2
• Efficacy and safety of insulin glargine/ lixisenatide fixed ratio combination compared to insulin glargine alone and lixisenatide alone on top of metformin in patients with T2DM — COMPLETED · PHASE3
• A factorial randomised trial of blood pressure lowering with a fixed low-dose perindopril-indapamide combination and intensive glucose control with a modified-release gliclazide-based regimen for the prevention of vascular disease among high risk individuals with type 2 diabetes — COMPLETED · PHASE3
• Pain Neuroscience Education and Graded Motor Imagery Combined With Conventional Physiotherapy on Diabetic Adhesive Capsulitis — NOT_YET_RECRUITING · NA
• Combination of Lactulose and Polyethylene Glycol Electrolytes Powder (PEG-ELS) for Bowel Preparation in Type II Diabetes Mellitus Patients — COMPLETED · NA
• Dual Task Performance and Type II Diabetes Mellitus — COMPLETED
• Short- and Long-Term Effects of Whole-Body Photobiomodulation in Type II Diabetes Patients: A Protocol for a Controlled Clinical Trial — NOT_YET_RECRUITING · NA
• Intrapartum Glycemic Control With Insulin Infusion Versus Rotating Fluids — COMPLETED · NA
• Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY) — ACTIVE_NOT_RECRUITING · PHASE2
• A Clinical Trial to Evaluate the Food Effect of CKD-379 — COMPLETED · PHASE1
• A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus — TERMINATED · PHASE3
• A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients — COMPLETED · PHASE3
• Relative Hand Grip Strength and Functional Fitness in Diabetic Patient in Egypt — COMPLETED · NA
• Using Technology to Share Fitness Goals and Results to Improve Diabetes Outcomes — COMPLETED · NA
• Effect of Pioglitazone on Mitochondrial Function in Muscle and Adipose Tissue in Humans — COMPLETED
• A Clinical Trial to Evaluate the Food Effect of CKD-378 — COMPLETED · PHASE1
• Effects of Eccentric Training on Glycemic Control and Quality of Life in Patients With Type II Diabetes Mellitus — OTHER · NA
• Metabolomics of Roux-en-Y Gastric Bypass (RYGB) With Gastrostomy — COMPLETED
• Efficacy and Safety of Atenas Association in the Treatment of Type II Diabetes Mellitus and Hypertension — WITHDRAWN · PHASE3
• Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and Hypertension — WITHDRAWN · PHASE3
• Study to Evaluate the Safety and Pharmacokinetics of CKD-379 — OTHER · PHASE1
• Dose Response of Eccentric Exercise on Glycemic Control in Type II Diabetes Mellitus — COMPLETED · NA
• Pharmacokinetics and Safety/Tolerability of CKD-379 — COMPLETED · PHASE1
• Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects — COMPLETED · PHASE1
• Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393 — COMPLETED · PHASE1
• Pharmacokinetics and Safety/Tolerability Profile of CKD-379 — COMPLETED · PHASE1
• A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics — TERMINATED · PHASE3
• Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure — COMPLETED · PHASE4
• Safety And Efficacy Of Empagliflozin In Pakistani Muslim Population With Type Ii Diabetes Mellitus — COMPLETED · PHASE4
• SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2 — COMPLETED · PHASE3

Refine this search